Opzelura™ (ruxolitinib) cream

About Incyte

Founded in 2002 and headquartered in Wilmington, Delaware, Incyte has evolved from a small team of scientists into a leading global biopharmaceutical company with three core franchises. The company maintains a robust pipeline with ongoing clinical trials in dozens of disease areas and has been recognized as a top employer by Science Magazine for eight consecutive years. With over 1,000 research and clinical development employees, Incyte continues to advance breakthrough treatments under their mission to 'Solve On' for patients worldwide.

About Ono Pharmaceutical

Ono Pharmaceutical Co., Ltd. is one of Japan's oldest and most established pharmaceutical companies with over 300 years of history. The company has evolved from traditional medicine to become a leader in oncology, particularly through its co-development of Opdivo with Bristol Myers Squibb, which has become one of the world's leading cancer immunotherapies. Ono maintains a strong focus on research and development with particular expertise in immunology, oncology, and CNS disorders, while expanding its presence in international markets.

Therapeutic Areas